Papers
1
Total Citations
275
H-Index
1
About
Tim Eisen is a leading oncologist whose research has fundamentally shaped the management of renal cell carcinoma (RCC). His most impactful work includes authoring the ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up of RCC, a seminal paper cited over 275 times that has become a global standard for clinical decision-making. Beyond this landmark guideline, Eisen has made major contributions to the development and clinical translation of targeted therapies and immunotherapies for kidney cancer, helping to transform a disease once considered uniformly fatal into a more manageable condition. His research has directly influenced how clinicians select and sequence treatments, improving outcomes for thousands of patients worldwide. Eisen’s work is distinguished by its integration of rigorous clinical trial evidence with practical, patient-centered recommendations. His contributions have earned him recognition as a key opinion leader in genitourinary oncology, and his guidelines remain essential reading for oncologists, trainees, and researchers seeking to understand the evolving landscape of RCC therapy.
Research Focus
Key Achievements
Top Papers
- 1